Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Clover Health Investments operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Clover Health Investments's operating cash flow for the twelve months ending Sep 30, 2026 was $135.31M. For fiscal 2025 it was -$66.93M, down 292.1% from the year before. The highest annual figure on record is $34.85M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$66.93M | -292.1% |
| FY2024 | Dec 31, 2024 | $34.85M | – |
| FY2023 | Dec 31, 2023 | -$144.66M | – |
| FY2022 | Dec 31, 2022 | -$203.93M | – |
| FY2021 | Dec 31, 2021 | -$282.33M | – |
| FY2020 | Dec 31, 2020 | -$118.50M | – |
| FY2019 | Dec 31, 2019 | -$159.88M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $70.38M | +481.5% |
| Q2 FY2026 | Jun 30, 2026 | $25.19M | +365.8% |
| Q1 FY2026 | Mar 31, 2026 | $107.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$68.15M | – |
| Q3 FY2025 | Sep 30, 2025 | $12.10M | -75.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.41M | -87.9% |
| Q1 FY2025 | Mar 31, 2025 | -$16.29M | -162.8% |
| Q4 FY2024 | Dec 31, 2024 | -$85.83M | – |
| Q3 FY2024 | Sep 30, 2024 | $49.99M | – |
| Q2 FY2024 | Jun 30, 2024 | $44.76M | -15.8% |
| Q1 FY2024 | Mar 31, 2024 | $25.94M | -67.2% |
| Q4 FY2023 | Dec 31, 2023 | -$258.09M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.78M | -118.5% |
| Q2 FY2023 | Jun 30, 2023 | $53.17M | – |
| Q1 FY2023 | Mar 31, 2023 | $79.03M | – |
| Q4 FY2022 | Dec 31, 2022 | -$209.37M | – |
| Q3 FY2022 | Sep 30, 2022 | $101.66M | – |
| Q2 FY2022 | Jun 30, 2022 | -$39.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.04M | – |
| Q4 FY2021 | Dec 31, 2021 | -$80.18M | – |
| Q3 FY2021 | Sep 30, 2021 | -$45.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$64.16M | -584.8% |
| Q1 FY2021 | Mar 31, 2021 | -$92.87M | – |
| Q4 FY2020 | Dec 31, 2020 | -$59.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.65M | – |
| Q2 FY2020 | Jun 30, 2020 | $13.23M | – |
| Q1 FY2020 | Mar 31, 2020 | -$37.18M | – |
See a number that looks wrong?